Biologics Price Competition And Innovation Act - Pharma

Relevant Publications

A Critical Analysis of the FDA\'s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity.

Issue Release: 2023

The availability of gonadotropin therapy from FDA-approved pharmacies for men with hypogonadism and infertility.

Issue Release: 2023

Biosimilar competition: Early learning.

Issue Release: 2022

The First Interchangeable Biosimilar Insulin: Insulin Glargine-yfgn.

Issue Release: 2021

Pegfilgrastim Biosimilars: Where Are We Now?

Issue Release: 2021

Barriers To US Biosimilar Market Growth: Lessons From Biosimilar Patent Litigation.

Issue Release: 2021

Recognizing and addressing challenges to the adoption of trastuzumab biosimilars and HER2-targeted therapies.

Issue Release: 2020

The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond.

Issue Release: 2019

Current and future roles of biosimilars in oncology practice.

Issue Release: 2019

Design and Analysis of Biosimilar Switching Studies.

Issue Release: 2019

Sowing confusion in the field: the interchangeable use of biosimilar terminology.

Issue Release: 2019

Strategies for Overcoming Barriers to Adopting Biosimilars and Achieving Goals of the Biologics Price Competition and Innovation Act: A Survey of Managed Care and Specialty Pharmacy Professionals.

Issue Release: 2019

The Case for Disclosure of Biologics Manufacturing Information.

Issue Release: 2019

Optimizing use and addressing challenges to uptake of biosimilars.

Issue Release: 2018

The complexities of biosimilars and the regulatory approval process.

Issue Release: 2018

FDA\'s Approval of the First Biosimilar to Bevacizumab.

Issue Release: 2018

Biosimilar Cost Savings in the United States: Initial Experience and Future Potential.

Issue Release: 2018

Approval Process: An Overview of Biosimilars in the Oncology Setting.

Issue Release: 2018

AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.

Issue Release: 2017

A Systematic Review of U.S. Biosimilar Approvals: What Evidence Does the FDA Require and How Are Manufacturers Responding?

Issue Release: 2017

How Can Pharma Companies Improve Patient Education?

What is Medication Management?

What Challenges Do Pharmacists Face?

How Can ADEs be Prevented?

What are the Key Challenges?

Why is Generic Competition Important?

What are Chronic Conditions?

What are the Implications for Pharma Companies?

How Does the Patent System Affect Generic Competition?

What is the Future of the Pharmacy Profession?

Partnered Content Networks

Relevant Topics